Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Other Proteins

Recombinant SARS-CoV-2 N/NP/Nucleoprotein Protein, C-Avi-His

Catalog #:   YVV00804 Specific References (50) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: E. coli
Accession: P0DTC9
Protein length: Thr247-Ala419
Overview

Catalog No.

YVV00804

Expression system

E. coli

Species

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

Protein length

Thr247-Ala419

Predicted molecular weight

22.41 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

P0DTC9

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

Nucleoprotein, N, Nucleocapsid protein, NC, Protein N, N, SARS-CoV-2

Data Image
  • SDS-PAGE
    SDS PAGE for Recombinant SARS-CoV-2 NP/Nucleoprotein protein
References

Convergent evolution in nucleocapsid facilitated SARS-CoV-2 adaptation for human infection., PMID:40503915

Dynamic ensembles of SARS-CoV-2 N-protein reveal head-to-head coiled-coil-driven oligomerization and phase separation., PMID:40503686

Genome-Wide Interrogation of SARS-CoV-2 RNA-Protein Interactions Uncovers Hidden Regulatory Sites., PMID:40501555

An efficient strategy for producing RNA-free Nucleocapsid protein of SARS-CoV-2 for biochemical and structural investigations., PMID:40490992

The effect of early COVID-19 treatment with convalescent plasma on antibody responses to SARS-CoV-2., PMID:40488473

SARS-CoV-2 N protein interacts with Nav1.7 to promote pathological pain., PMID:40488276

Single-particle quantification of SARS-CoV-2 virus-like particles using flow virometry., PMID:40483334

Bats from an area of the Colombian Caribbean reveal the circulation of Alphacoronavirus., PMID:40476071

Seroprevalence Trends of Antibodies to SARS-CoV-2 in South Korea, 2021-2022: A Repeated Cross-Sectional Study., PMID:40462400

SARS-CoV-2-specific humoral immunity in a Norwegian cohort between 2020 and 2023., PMID:40462062

Wastewater dataset on the SARS-CoV-2 sublineages circulating in Central Arkansas, USA, post-COVID-19 pandemic., PMID:40461497

SARS-CoV-2 N protein exerts antitumor effects in NSCLC by inducing DNA damage and augmenting chemotherapeutic sensitivity., PMID:40451965

The Overlooked Nucleocapsid Response: A Cohort Study of SARS-CoV-2 Vaccines in Brazil., PMID:40430765

Intrinsic Factors Behind Long COVID: VI. Combined Impact of G3BPs and SARS-CoV-2 Nucleocapsid Protein on the Viral Persistence and Long COVID., PMID:40415285

SERS-based lateral flow immunoassay for rapid and sensitive sensing of nucleocapsid protein toward SARS-CoV-2 screening in clinical samples., PMID:40409906

ELV-N34, RvD6-Isomer, or NPD1 Halt Replication of SARS-CoV-2 Omicron BA.5 Virus in Human Lung and Nasal Cells., PMID:40407038

Lymphocyte Subsets in Covid-19 Saudi Patients: Infection Caused Significant Reduction in Peripheral Blood Lymphocyte Subset., PMID:40387754

Plasmonic coffee-ring biosensing for AI-assisted point-of-care diagnostics., PMID:40382337

Phosphorylation Changes SARS-CoV-2 Nucleocapsid Protein's Structural Dynamics and Its Interaction With RNA., PMID:40375582

Natural product sennoside B disrupts liquid-liquid phase separation of SARS-CoV-2 nucleocapsid protein by inhibiting its RNA-binding activity., PMID:40371698

Development of monoclonal antibodies against SARS-CoV-2 nucleocapsid protein for COVID-19 antigen detection., PMID:40361217

Coupling of SARS-CoV-2 to Amyloid Fibrils and Liquid-Liquid Phase Separation., PMID:40353409

Designing a multi-epitope universal vaccine for concurrent infections of SARS-CoV-2 and influenza viruses using an immunoinformatics approach., PMID:40348967

Transfer of SARS-CoV-2 nucleocapsid protein to uninfected epithelial cells induces antibody-mediated complement deposition., PMID:40343796

SARS-CoV-2 N protein interacts with SLC7A11 to cause ferroptosis in acute lung injury., PMID:40342111

Plasma SARS-CoV-2 nucleocapsid antigen levels are associated with lung infection and tissue-damage biomarkers., PMID:40339608

SARS-CoV-2 N protein induces hypokalemia in acute kidney injury mice via ENaC-dependent mechanism., PMID:40336195

PBS-DLS: A Novel Ultrasensitive Dynamic Light Scattering Immunoassay., PMID:40327829

High-resolution structure reveals enhanced 14-3-3 binding by a mutant SARS-CoV-2 nucleoprotein variant with improved replicative fitness., PMID:40318379

Ultra-sensitive heterojunction double gate BioTFET device for SARS-CoV-2 biomolecules detection., PMID:40307462

No Evidence of SARS-CoV-2 Infection in Urban Wildlife of Hokkaido, Japan., PMID:40303042

Variant mutation G215C in SARS-CoV-2 nucleocapsid enhances viral infection via altered genomic encapsidation., PMID:40299982

SARS-CoV-2 N protein and anti-spike serologies: insights into COVID-19 disease severity and mortality-a secondary analysis of the ACTIV-1 trial., PMID:40297751

The Clinical and Laboratory Landscape of COVID-19 During the Initial Period of the Pandemic and at the Beginning of the Omicron Era., PMID:40284924

Nuclear shuttling of CDC4 mediated broad-spectrum antiviral activity against diverse coronaviruses., PMID:40260685

Identification and Characterization of a Novel Protein-Protein Interaction Among SARS-CoV-2 Nucleocapsid, Host SFPQ, and hnRNP U and Its Potential Role in Virus Replication., PMID:40259455

SARS-CoV-2 nucleocapsid protein induces a Mincle-dependent macrophage inflammatory response in acute kidney injury., PMID:40244324

Deep Learning-Based Comparative Prediction and Functional Analysis of Intrinsically Disordered Regions in SARS-CoV-2., PMID:40244295

Developing Zika virus-transduced hACE2 expression models for severe acute respiratory syndrome coronavirus 2 infection in vitro and in vivo., PMID:40239870

Construction and immunogenicity analysis of a recombinant baculovirus targeting the N protein of SARS-CoV-2., PMID:40237823

CLIA immunoassay as an alternative and accurate method to detect Sars-Cov-2 antigen compared to ELISA., PMID:40220581

Optimization of A549 Cell Transfection Efficiency with a Plasmid Encoding the N-Protein of the SARS-CoV-2 Virus., PMID:40216710

Pushing the Limits of Lateral Flow Immunoassay by Digital SERS for the Ultralow Detection of SARS-CoV-2 Virus., PMID:40213455

DeepATsers: a deep learning framework for one-pot SERS biosensor to detect SARS-CoV-2 virus., PMID:40210912

Assessment of genetic diversity, tissue tropism, and antigenic properties of Grimsö betacoronavirus in Swedish bank voles (Clethrionomys glareolus)., PMID:40206840

Development of an ELISA Test with High Diagnostic Accuracy for SARS-COV-2 Using Recombinant Nucleocapsid Protein Expressed in E. coli., PMID:40193039

Targeting USP22 to promote K63-linked ubiquitination and degradation of SARS-CoV-2 nucleocapsid protein., PMID:40183543

Rapid Detection of SARS-CoV-2 in Clinical Samples Combining a Paper-Based Immunoassay With SERS-Based Read out and Machine Learning., PMID:40156372

Detection of IgG Antibodies Against COVID-19 N-Protein by Hybrid Graphene-Nanorod Sensor., PMID:40136961

Nucleocapsid-directed antibody testing is unsuitable to estimate hybrid immunity against SARS-CoV-2, a longitudinal cross-border study in the Meuse-Rhine Euroregion., PMID:40132351

Datasheet
$ 313
Product specifications
100 μg 313 1 mg 1629

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant SARS-CoV-2 N/NP/Nucleoprotein Protein, C-Avi-His [YVV00804]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only